ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

Varmus, Duke Ask IOM To Investigate Potti’s Scientific Work, Clinical Trials

July 30, 2010

Cell Phone Radiation Does Not Raise Child’s Risk of Tumors

August 26, 2011

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

Worker Health RFA May Finally Be Ready

August 26, 1988

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

Congressman Carter To Address ACCC Annual Conference

December 3, 1976